Stock HOWL WEREWOLF THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
6.07 USD -0.16% Intraday chart for Werewolf Therapeutics, Inc. -10.07% +57.25%
05-03 Werewolf Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-23 Werewolf Therapeutics, Inc. Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease at AAI Annual Meeting CI

Evolution of the average Target Price on Werewolf Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

bc1e8d6e7072e5.jX3Tz2FQBlbYgNclTWAlfFY1GeQpo72mvnsbFgs-Mx4.wz6dqQxkdQyd-INPKFFsGTVCV4BY4PmUyipeQFoJfCm4HpGqVCZpPp_3oA~56f0efb405a59ffdfb0ef95f3385dedd

Analyst Recommendations on Werewolf Therapeutics, Inc.

JMP Securities Starts Werewolf Therapeutics With Market Outperform Rating, $12 Price Target MT
Wedbush Starts Werewolf Therapeutics at Outperform With $9 Price Target MT
EF Hutton Starts Werewolf Therapeutics at Buy With $8.30 Price Target MT
History shows stocks can weather rate hike cycle RE
SVB Leerink Adjusts Werewolf Therapeutics' Price Target to $28 from $29, Keeps Outperform Rating MT
WEREWOLF THERAPEUTICS : BofA Securities Initiates Coverage on Werewolf Therapeutics With Buy Rating, $26 Price Target MT
WEREWOLF THERAPEUTICS : Evercore ISI Group Initiates Werewolf Therapeutics at Outperform With $23 Price Target MT
WEREWOLF THERAPEUTICS : SVB Leerink Initiates Coverage on Werewolf Therapeutics With Outperform Rating, $29 Price Target MT
WEREWOLF THERAPEUTICS : HC Wainwright Starts Werewolf Therapeutics at Buy With $32 Price Target MT
WEREWOLF THERAPEUTICS : Jefferies Starts Werewolf Therapeutics at Buy With $22 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
6.07 USD
Average target price
12.5 USD
Spread / Average Target
+105.93%
High Price Target
15 USD
Spread / Highest target
+147.12%
Low Price Target
9 USD
Spread / Lowest Target
+48.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Werewolf Therapeutics, Inc.

JMP Securities
Wedbush
EF Hutton
SVB Leerink
BofA Securities
Jefferies & Co.
HC Wainwright
Evercore ISI

Ratings for Werewolf Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HOWL Stock
  4. Consensus Werewolf Therapeutics, Inc.